Affiliation:
1. Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria
Abstract
ABSTRACT
We compared the activities of antifungal agents against a wide range of yeasts and filamentous fungi. The methodology of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for yeasts and spore-forming molds was applied; and a total of 349 clinical isolates of
Candida
spp., other yeast species,
Aspergillus
spp., and nondermatophyte non-
Aspergillus
spp. were investigated. The average geometric mean (GM) of the MICs of the various drugs for
Candida
spp. were as follows: amphotericin B (AMB), 0.55 μg/ml; liposomal amphotericin B (l-AMB); 0.35 μg/ml; itraconazole (ITC), 0.56 μg/ml; voriconazole (VRC), 0.45 μg/ml; posaconazole (POS), 0.44 μg/ml; and caspofungin (CPF), 0.45 μg/ml. The data indicated that the majority of
Candida
spp. were susceptible to the traditional and new antifungal drugs. For
Aspergillus
spp., the average GM MICs of AMB, l-AMB, ITC, VRC, POS, and CPF were 1.49 μg/ml, 1.44 μg/ml, 0.65 μg/ml, 0.34 μg/ml, 0.25 μg/ml, and 0.32 μg/ml, respectively. For the various zygomycetes, the average GM MICs of AMB, l-AMB, ITC, and POS were 1.36 μg/ml, 1.42 μg/ml, 4.37 μg/ml, and 1.65 μg/ml, respectively. Other yeastlike fungi and molds displayed various patterns of susceptibility. In general, the minimal fungicidal concentrations were 1 to 3 dilutions higher than the corresponding MICs. POS, AMB, and l-AMB showed activities against a broader range of fungi than ITC, VRC, and CPF did. Emerging pathogens such as
Saccharomyces cerevisiae
and
Fusarium solani
were not killed by any drug. In summary, the EUCAST data showed that the in vitro susceptibilities of yeasts and filamentous fungi are variable, that susceptibility occurs among and within various genera and species, and that susceptibility depends on the antifungal drug tested. AMB, l-AMB, and POS were active against the majority of pathogens, including species that cause rare and difficult-to-treat infections.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献